Table 1 Clinical characteristics and baseline comorbidities summary
Pulmonary vascular stump filling defects | P | |||
|---|---|---|---|---|
No (N = 80) | Convex (N = 46) | Concave (N = 31) | ||
Gender: | 0.026 | |||
Male | 49(61.3%)# | 38(82.6%) | 24(77.4%) | |
Female | 31(38.8%) | 8(17.4%) | 7(22.6%) | |
Age, years: | 62.6 ± 8.56 | 61.8 ± 7.11 | 63.7 ± 7.14 | 0.609 |
Histological types: | 0.501 | |||
Large cell | 2(2.50%) | 2(4.35%) | 1(3.23%) | |
Squamous cell | 21(26.2%) | 18(39.1%) | 9(29.0%) | |
Adenocarcinoma | 53(66.2%) | 22(47.8%) | 18(58.1%) | |
Small cell | 4(5.00%) | 4(8.70%) | 3(9.68%) | |
Stage of cancer at surgery: | 0.270 | |||
Stage I/II | 61(76.3%) | 29(63.0%) | 21(67.7%) | |
Stage III/IV | 19(23.7%) | 17(37.0%) | 10(32.3%) | |
Surgical intervention: | 0.322 | |||
Right side | 50(62.5%) | 23(50.0%) | 16(51.6%) | |
Left side | 30(37.5%) | 23(50.0%) | 15(48.4%) | |
Length of vascular stump (cm) | 0.61 ± 0.73& | 1.33 ± 0.81 | 1.60 ± 0.89 | < 0.001 |
Tumor progression | 22(27.5%) | 12(26.1%) | 18(58.1%)* | 0.003 |
Diabetes mellitus: | 9(11.2%) | 6(13.0%) | 5(16.1%) | 0.785 |
Arterial hypertension: | 15(18.8%) | 7(15.2%) | 10(11.2%) | 0.167 |
Coronary disease: | 6(7.50%) | 7(15.2%) | 3(3.22%) | 0.392 |
Smoking: | 12(15.0%) | 9(19.6%) | 7(22.6%) | 0.604 |
BMI (BMI ≥ 25): | 4(5.00%) | 5(10.9%) | 1(11.2%) | 0.419 |
Previous VTED: | 7(8.75%) | 7(15.2%) | 4(3.22%) | 0.505 |
Atrial fibrillation: | 3(3.75%) | 1(2.17%) | 1(3.22%) | 1.000 |
Fibrinogen Degrdtion Product abnormal | 3(3.75%) | 3(6.52%) | 4(12.9%) | 0.245 |
D-Dimer>500ug/l | 2(4.82%) | 3(6.52%) | 3(9.68%) | 0.270 |